Northern Trust Corp Bridge Bio Pharma, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,279,303 shares of BBIO stock, worth $46.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,279,303

Previous 1,129,019 13.31%

Holding current value

$46.2 Million

Previous $28.6 Million 13.89%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$23.91 - $31.3 $3.59 Million - $4.7 Million	150,284 Added 13.31%	1,279,303 $32.6 Million
Q2 2024 Aug 14, 2024	SELL	$23.0 - $31.04 $4,370 - $5,897	-190 Reduced 0.02%	1,129,019 $28.6 Million
Q1 2024 May 14, 2024	SELL	$27.35 - $40.45 $704,618 - $1.04 Million	-25,763 Reduced 2.23%	1,129,209 $34.9 Million
Q4 2023 Feb 13, 2024	BUY	$24.02 - $43.89 $25,389 - $46,391	1,057 Added 0.09%	1,154,972 $46.6 Million
Q3 2023 Nov 13, 2023	BUY	$16.89 - $35.01 $416,220 - $862,751	24,643 Added 2.18%	1,153,915 $30.4 Million
Q2 2023 Aug 11, 2023	BUY	$13.29 - $18.01 $2.28 Million - $3.1 Million	171,915 Added 17.96%	1,129,272 $19.4 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $116,075 - $300,305	16,189 Added 1.72%	957,357 $15.9 Million
Q4 2022 Feb 13, 2023	BUY	$6.74 - $11.52 $34,576 - $59,097	5,130 Added 0.55%	941,168 $7.17 Million
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $242,273 - $377,140	-30,513 Reduced 3.16%	936,038 $9.31 Million
Q2 2022 Aug 12, 2022	SELL	$5.21 - $12.14 $160,150 - $373,171	-30,739 Reduced 3.08%	966,551 $8.78 Million
Q1 2022 May 13, 2022	SELL	$7.34 - $17.16 $106,268 - $248,442	-14,478 Reduced 1.43%	997,290 $10.1 Million
Q4 2021 Feb 08, 2022	SELL	$11.38 - $53.41 $1.18 Million - $5.53 Million	-103,631 Reduced 9.29%	1,011,768 $16.9 Million
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $1.75 Million - $2.4 Million	37,336 Added 3.46%	1,115,399 $52.3 Million
Q2 2021 Aug 13, 2021	BUY	$46.47 - $63.93 $2.28 Million - $3.14 Million	49,053 Added 4.77%	1,078,063 $65.7 Million
Q1 2021 May 12, 2021	BUY	$55.47 - $72.35 $10.9 Million - $14.2 Million	196,174 Added 23.55%	1,029,010 $63.4 Million
Q4 2020 Feb 11, 2021	SELL	$38.38 - $71.11 $756,239 - $1.4 Million	-19,704 Reduced 2.31%	832,836 $59.2 Million
Q3 2020 Nov 16, 2020	BUY	$27.2 - $42.19 $1.69 Million - $2.62 Million	62,103 Added 7.86%	852,540 $32 Million
Q2 2020 Aug 14, 2020	BUY	$22.22 - $35.69 $187,870 - $301,758	8,455 Added 1.08%	790,437 $25.8 Million
Q1 2020 May 14, 2020	BUY	$16.11 - $36.23 $7.64 Million - $17.2 Million	474,058 Added 153.95%	781,982 $22.7 Million
Q4 2019 Feb 14, 2020	BUY	$17.96 - $46.63 $162,232 - $421,208	9,033 Added 3.02%	307,924 $10.8 Million
Q3 2019 Nov 13, 2019	BUY	$20.13 - $32.38 $6.02 Million - $9.68 Million	298,891 New	298,891 $6.42 Million
Q2 2019 Aug 13, 2019	BUY	$26.97 - $27.55 $0 - $0	0 New	0 $0

Others Institutions Holding BBIO

# of Institutions

295

Shares Held

170M

Call Options Held

10.4M

Put Options Held

2.36M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.35B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Bridge Bio Pharma, Inc. Transaction History